Jamie Dimon is right to be alarmed about our national-security vulnerabilities, especially an overreliance on China and India for generic prescription drugs (“Investments for National Security,” op-ed ...

The last 12 months have been a bit boring for Novartis AG (NYSE:NVS) and have resulted in a lack of my coverage updates on the company. The stock has delivered a total return of around 18% since my ...

As the US and Europe experiences shortages of crucial medicines, Ben Hargreaves looks at how a once thriving generics industry is now struggling, with many companies seeking to exit the space. Generic ...

Faced with the prospect of tariffs on imported medicines threatened by the Trump administration, Indian drugmaker Hikma has said it will spend $1 billion to expand its manufacturing and R&D operations ...

New York Times Coverage Avoids the Third Rails of Sex Trafficking Pro-lifers were disturbed when news broke of the FDA’s approval of a generic form of the “abortion pill,” mifepristone, to be produced ...

NovartisNVS stock undercut the lower boundary of its chase zone Tuesday after generics took a big bite out of Entresto, the heart-failure drug that accounts for 13% of the Swiss company's sales.

Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has ...

Margo Martindale and Natalie Portman are among the voice cast for this Phil Johnston-directed version of the beloved author’s ickiest book. By Richard Lawson While some young Roald Dahl fans, like me, ...

Danish vaccine developer Evaxion has released long-term data for its lead personalized cancer vaccine, with the shot scoring a 75% objective response rate (ORR) in patients with advanced melanoma ...

The Rasmussen Reports daily Presidential Tracking Poll for Tuesday shows that 45% of Likely U.S. Voters approve of President Trump’s job performance. Fifty-three (53%) disapprove. The latest figures ...